Navigation Links
Lexicon Files Investigational New Drug Application for LX1032 as a Potential Treatment for Carcinoid Syndrome
Date:12/21/2007

gic alliances and intellectual property, as well as other matters that are not historical facts or information. All forward-looking statements are based on management's current assumptions and expectations and involve risks, uncertainties and other important factors, specifically including those relating to Lexicon's ability to successfully conduct clinical development of LX1032 and preclinical and clinical development of its other potential drug candidates, advance additional candidates into preclinical and clinical development, obtain necessary regulatory approvals, achieve its operational objectives, obtain patent protection for its discoveries and establish strategic alliances, as well as additional factors relating to manufacturing, intellectual property rights, and the therapeutic or commercial value of its drug candidates, that may cause Lexicon's actual results to be materially different from any future results expressed or implied by such forward-looking statements. Information identifying such important factors is contained under "Factors Affecting Forward-Looking Statements" and "Risk Factors" in Lexicon's annual report on Form 10-K for the year ended December 31, 2006, as filed with the Securities and Exchange Commission. Lexicon undertakes no obligation to update or revise any such forward-looking statements, whether as a result of new information, future events or otherwise.


'/>"/>
SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Lexicon Presents Class of Compounds Modulating TPH1, the Target for its LX1031 Investigational Drug for Irritable Bowel Syndrome
2. Lexicon Pharmaceuticals to Present at the UBS Global Life Sciences Conference
3. Lexicon Appoints Judith Swain, M.D. to Board of Directors
4. Lexicon Pharmaceuticals to Present at ThinkEquity ThinkClinic
5. Lexicon Pharmaceuticals to Present at Bio InvestorForum
6. Lexicon to Report Third Quarter 2007 Financial Results on October 30, 2007
7. Lexicon Pharmaceuticals Reports 2007 Third Quarter Financial Results
8. Lexicon Pharmaceuticals to Present at the Piper Jaffray 19th Annual Health Care Conference
9. Lexicon Pharmaceuticals to Present at RBC Capital Markets Healthcare Conference
10. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
11. ImmuneRegen BioSciences Files 8-K that Highlights Enclosed Shareholder Letter Discussing Recent Achievements and Outlook
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/5/2015)... (PRWEB) May 05, 2015 Hayden-McNeil ... services to develop custom course materials for smaller courses. ... enrollments as low as 200 students. , “I’m ... broader range of higher education instructors,” said Jeff McCarthy, ... country, we can do our part to make education ...
(Date:5/5/2015)... SAN DIEGO , May 5, 2015 /PRNewswire-USNewswire/ ... treatments for congestive heart failure and other chronic ... create an independent analysis designed to reflect the ... over time. This model will be used to ... for CHF, could have on those groups of ...
(Date:5/5/2015)... May 05, 2015 Franz Inc ., ... today announced that its flagship product, AllegroGraph, has been named ... Database Market Update report. AllegroGraph is a high ... W3C industry standards. Graph databases are skyrocketing in popularity and ... to a recent DBMS ranking by DB-Engines. , ...
(Date:5/5/2015)...   Tocagen Inc. , a clinical-stage immuno-oncology ... , M.D., a venture partner at New Enterprise ... of directors of Tocagen. Dr. Parkinson has more ... development, including leading clinical activities at Amgen and ... cancer therapeutics Gleevec®, Femara®, Zometa®, Kepivance® and Vectibix®, ...
Breaking Biology Technology:Hayden-McNeil Expands Publishing Program to Service Lower Enrollment Courses 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 2RAND Health Advisory Services modeling heart failure patient outcomes to inform potential impact of Renova Therapeutics lead product candidate 3Bloor Research Positions AllegroGraph as a ‘Champion’ in Burgeoning Graph Database Market 2Bloor Research Positions AllegroGraph as a ‘Champion’ in Burgeoning Graph Database Market 3Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 2Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 3Tocagen Appoints David R. Parkinson, M.D., to the Board of Directors 4
... Results from a landmark trial published today in the ... kidneys preserved and transported in a specially designed machine ... in recovery of kidney function are 43% lower, and ... within a year compared to those stored in the ...
... Calif., Dec. 31 The United States Food & Drug,Administration ... to,screen donated blood for HIV-1 Group M RNA, hepatitis C ... test, called the cobas TaqScreen MPX,Test for use on the ... for,comprehensive single-assay detection of HIV-1 Group M RNA, HIV-1 Group ...
... Md., Dec. 30 Martek Biosciences Corporation (Nasdaq: ... the upcoming Needham & Company 11th Annual Growth Conference in ... 6-8, 2009 at the New York Palace Hotel. Peter ... 2009, at 11:30 a.m. Eastern Time.A live audio webcast of ...
Cached Biology Technology:Kidneys for Transplant Function Earlier and Last Longer When Preserved in a Machine Compared to the Traditional Box of Ice 2Kidneys for Transplant Function Earlier and Last Longer When Preserved in a Machine Compared to the Traditional Box of Ice 3Kidneys for Transplant Function Earlier and Last Longer When Preserved in a Machine Compared to the Traditional Box of Ice 4Kidneys for Transplant Function Earlier and Last Longer When Preserved in a Machine Compared to the Traditional Box of Ice 5FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C 2FDA Approves Most Comprehensive System to Test Donated Blood for HIV, Hepatitis B & Hepatitis C 3
(Date:3/24/2015)... and Markets ( http://www.researchandmarkets.com/research/kvdtcw/face_and_voice ) has announced the addition ... Report" report to their offering. This report analyzes ... by the following Segments: Face Biometrics, and Voice Biometrics. The report ... , Japan , Europe , ... & Africa , and Latin America ...
(Date:3/24/2015)... , March 24, 2015   Crossmatch ... solutions, today announced that its U.are.U ® ... retailer Goorin Bros . to achieve PCI ... solution secures access to the POS terminal, protecting ... risk of data breaches. With ...
(Date:3/23/2015)... NEW YORK , March 23, 2015   ... digital property management company, today announced that the Company ... platform for both enterprise and consumers at Connect:ID on ... D.C. HOYOS Labs will highlight the IEEE ... 1U TM ; and enterprise access control system. ...
Breaking Biology News(10 mins):Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 2Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 3Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 4Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 5Face and Voice Biometrics - Global Strategic Business Report 2015: Face Recognition Gains Prominence in Immigration Control 6Crossmatch Fingerprint Readers Help Retailer Prevent Data Breaches at Point-of-Sale 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 2HOYOS Labs to Showcase Host of Biometrics Technologies at Connect:ID in Washington, D.C. 3
... Science Translational Medicine , examines the structures of translational ... been written by researchers from the National Institute for ... Guy,s and St Thomas, and King,s College London. ... charitable investment in translational research taking place within the ...
... been shown to rapidly deplete the levels of vitamin E in ... found. Stored levels of this important antioxidant were reduced more ... An analysis of eight children with third-degree burns over much ... vitamin E in three weeks, even though they were being given ...
... climate warms, species are expected to shift their geographical ranges ... While scientists have documented such shifts for many plants and ... respond in different ways to the same amount of warming, ... effects of climate change--and to plan for these effects. ...
Cached Biology News:Strategies for translational research in the UK 2Burn injuries rapidly deplete vitamin E 2Burn injuries rapidly deplete vitamin E 3Climate change may create tipping points for populations, not just species 2
Request Info...
Candida (IgG) -Ab EIA Sample Size: 5 l...
... EIA Principle: The Oxidized LDL Competitive ... Oxidized LDL in the sample competes with a ... microtiter well for the binding of the biotin- ... Size: 25 l The Oxidized LDL ...
... used with its manganese-containing reaction buffer, converts ... of short (1825 bp) interfering RNAs (siRNA) ... 1.3 units (1 l) of ShortCut RNase ... of dsRNA into siRNA suitable for RNA ...
Biology Products: